Literature DB >> 11096028

Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.

S Chakrabarti1, K E Collingham, K Holder, S Oyaide, D Pillay, D W Milligan.   

Abstract

Parainfluenza virus (PIV) infection can be a problem among hematopoetic stem cell transplant recipients. 125 patients were prospectively evaluated for respiratory viral infections. We describe 5 patients with PIV 3 infection and their response to early treatment with ribavirin.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11096028     DOI： 10.1086/317482

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  21 in total

1.  Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.

Authors:  Celalettin Ustun; Jiří Slabý; Ryan M Shanley; Jan Vydra; Angela R Smith; John E Wagner; Daniel J Weisdorf; Jo-Anne H Young
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-21       Impact factor: 5.742

2.  Characterizing the Cellular Immune Response to Parainfluenza Virus 3.

Authors:  Paibel I Aguayo-Hiraldo; Reuben J Arasaratnam; Ifigeneia Tzannou; Manik Kuvalekar; Premal Lulla; Swati Naik; Caridad A Martinez; Pedro A Piedra; Juan F Vera; Ann M Leen
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

3.  Respiratory disease due to parainfluenza virus in adult leukemia patients.

Authors:  J A Marcolini; S Malik; D Suki; E Whimbey; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-18       Impact factor: 3.267

4.  Risk Factors for Parainfluenza Virus Lower Respiratory Tract Disease after Hematopoietic Cell Transplantation.

Authors:  Sachiko Seo; Hu Xie; Wendy M Leisenring; Jane M Kuypers; Farah T Sahoo; Sonia Goyal; Louise E Kimball; Angela P Campbell; Keith R Jerome; Janet A Englund; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-25       Impact factor: 5.742

Review 5.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

6.  Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient.

Authors:  Takahiro Shima; Goichi Yoshimoto; Atsushi Nonami; Shuro Yoshida; Kenjiro Kamezaki; Hiromi Iwasaki; Katsuto Takenaka; Toshihiro Miyamoto; Naoki Harada; Takanori Teshima; Koichi Akashi; Koji Nagafuji
Journal:  Int J Hematol       Date:  2008-08-19       Impact factor: 2.490

7.  Current management of parainfluenza pneumonitis in immunocompromised patients: a review.

Authors:  Ann R Falsey
Journal:  Infect Drug Resist       Date:  2012-08-08       Impact factor: 4.003

Review 8.  Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus.

Authors:  Hans H Hirsch; Rodrigo Martino; Katherine N Ward; Michael Boeckh; Hermann Einsele; Per Ljungman
Journal:  Clin Infect Dis       Date:  2012-09-28       Impact factor: 9.079

Review 9.  The challenge of respiratory virus infections in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh
Journal:  Br J Haematol       Date:  2008-09-10       Impact factor: 6.998

10.  Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome.

Authors:  Sachiko Seo; Hu Xie; Angela P Campbell; Jane M Kuypers; Wendy M Leisenring; Janet A Englund; Michael Boeckh
Journal:  Clin Infect Dis       Date:  2014-03-05       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.